Tian Zhang, MD, MHS
@tiansterzhang
I treat & research GU cancers @UTSW Dallas. Columbia/Harvard Med/Duke alum; Mom & wife Tweets=my opinions ASCO: coi.asco.org/share/3UF-6U3Z…
ID: 2171015611
02-11-2013 22:06:07
8,8K Tweet
7,7K Followers
966 Following
Overview of treatment of metastatic #bladdercancer (mBC)👉comprehensive talk by Parminder singh Mayo Clinic at the #WorldGU24 World GU Conference 👉Treatment paradigm in mBC has exponentially advanced in the last decade👇 UroToday.com OncoAlert
How to manage side effects (AEs) of enfortumab vedotin in patients with #bladdercancer 👉safety correlates with drug exposure, dose reduction is an effective way to manage AEs👇 Excellent talk by Sandy Srinivas at the #WorldGU24 World GU Conference, UroToday.com OncoAlert Bladder Cancer Advocacy Network
Just a few great moments World GU Conference #WorldGU24 — Hannah Dzimitrowicz McManus & Melissa A. Reimers rising GU stars, supermen Bradley McGregor #BrantInman w medals, Ashish M. Kamat, MD, MBBS who I never see in Texas, & Lauren Meehan Machos, MPH longtime industry friend! Many moments & friends not captured. Thanks IDEOlogy Health!
Congrats to Glenda Delgado Ramos, MD & @charlesjiangmd for their selection to receive the Winn Awards Diversity in Clinical Trials Career Development Award. These are competitive 2-year awards recognizing their outstanding achievements. Thank you for your contributions to @UTSWCancer
Awesome — congrats Charles Jiang MD, MPH one of the John Quale Travel Fellows Bladder Cancer Advocacy Network #BCANTT24! Thanks Petros Grivas for supporting our rising star UTSW Hematology & Oncology UTSW Simmons Cancer Center UT Southwestern Medical Center!
#BCANTT24 Sarah P. Psutka MD MS kicks off patient centered clinical research YIA! Amazing leadership by Sarah and Peter Clark MD for the Bladder Cancer Advocacy Network YIA!
#BCANTT24 Andrea Apolo, M.D. gave a great overview of key practice changing trials in #bladderca #EV302 & #CM901 & strategies to close the gap on actual uptake of new therapies for patients in real world. Need to use implementation Sci!
Combo Abi-olaparib better than sequential for BRCA1/2/ATM mutated #prostatecancer. Glad to see #BRCAaway published! Congrats #MahaHussain Neeraj Agarwal, MD, FASCO et al! PCF Science OncoAlert UroToday.com
Looks like an amazing meeting of the minds for #BCANTT24 Petros Grivas Shilpa Gupta Sarah P. Psutka MD MS Charles Jiang MD, MPH Ashish M. Kamat, MD, MBBS et al!
At #KCRS24 Dr. Xiankai Sun UT Southwestern Medical Center shared groundbreaking advancements in using PET imaging to target HIF2α in #kidneycancer. Be sure to explore all the slides and videos from KCRS24 on our website! kcrs.kidneycan.org #AcceleratingCures
Belzutifan significantly outperformed everolimus in heavily pretreated clear cell renal cancer. Toni Choueiri, MD Brian Rini, MD Laurence Albiges ⬆️ RR, PFS, QOL but no OS. Data suggests belzutifan is better in less heavily treated disease and in combination. 1st line and adjuvant trials awaited
Happening now UTSW Internal Medicine grand rounds in D1.502 — #DanielWang highlights history & much clinical progress for immunotx across dz spectrum for #melanoma! Thorough overview & novel targets in pipeline! UTSW Simmons Cancer Center UTSW Hematology & Oncology Thomas Wang, MD Suzanne Conzen Carlos L. Arteaga, M.D.
T -3 weeks til #ESMO24! Presidential plenaries are online — ⭐️ 9/14 silke gillessen #PEACE3 radium-enza vs enza in #prostatecancer ⭐️ 9/15 Tom Powles #NIAGARA durva-chemo in #bladdercancer, discussed by Petros Grivas! See you in Barcelona! #ESMOAmbassadors ESMO - Eur. Oncology OncoAlert
Congrats Cathy Handy Marshall, MD MPH Benjamin Teply Emmanuel Antonarakis for ADT-sparing olaparib monotherapy in HRR altered #prostatecancer!
Congratulations! Qing Zhang Malladi Lab - UTSW !
